SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABTI Alpha-Beta Technology
ABTI 0.200+99,900.0%Jun 17 12:34 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rosemary who wrote (320)7/29/1997 12:03:00 AM
From: Zachary Prensky   of 572
 
Speaking to a few institutional players behind the August 10 Calls, many are saying that they'd exercize if the trials are succesful for a 6-9 month gamble on the FDA approval. Consensus seems to be 13-16 on the open if the phase III was positive, and $3/sh if it wasn't. My own personal inclination (I own the August 10s) is to hold a few days
after the announcement until all the short term holders have sold
(there are over 23,000 contracts, open, representing 2.3 million shares) and then hopefully watch some mutual funds pick up for the long haul. My own back of the envelope calculations says ABTI is worth $40/sh. post FDA approval.

ZP
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext